Tech Company Financing Transactions
TorreyPines Therapeutics Funding Round
On 6/30/2006, TorreyPines Therapeutics raised $6.4 million in funding from Advent International, Alta Partners and GIMV.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$6,364,000
Round
Undisclosed
Investors
Advent International (Jason Fisherman)
Alta Partners (Jean Deleage)
GIMV (Patrick Beneden)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
11085 N Torrey Pines Road 300
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Email Address
Overview
We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing novel small molecules to treat diseases and disorders of the central nervous system (CNS).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Evelyn Graham
Chief Financial Officer
Craig Johnson
VP - General Counsel
Paul Schneider
VP - Product Management
Sue Mellberg
Browse more venture capital transactions:
Prev: 6/30/2006: Batanga venture capital transaction
Next: 6/30/2006: Panasas venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs